Hotspot mutations in PIK3CA are predictive for treatment outcome on aromatase inhibitors but not for tamoxifen. - Ramirez, Ardila D. E.; C. Helmijr, J.; Lurkin, I.; Look, M.; Ruigrok-Ritstier, K.; Simon, I.; Van Laere, S.; Sweep, F.; Span, P.; Linn, S.; Foekens, J.; Sleijfer, S.; et al. (Cancer Research, 2012)